A systematic review of 76 different clinical trials looking at the risk of gallbladder disease for people taking GLP-1 agonists showed that there was an increase in risk for the development of gallbladder disease when taken at higher doses for long periods of time
This increased transmission of pulsatile and high-pressure blood flow into the cerebral circulation is associated with cerebral microvascular damage, which contributes to chronic reductions in CBF seen with aging and disease (Suri et al., 2020)
For many people with lupus, especially those with obesity, diabetes, or high cardiovascular risk, these medicines may be worth discussing with their healthcare team
GLP-1 medications help manage metabolic symptoms , particularly weight gain and blood sugar instability
Use a gentle cleanser suitable for your skin type
Setting reasonable expectations is essential, as is recognizing that the results may not be exactly what was anticipated
